Year To Quarter End Consolidated Statement Of Comprehensive Income

Oncolys BioPharma Inc. - Filing #7587326

Concept 2022-01-01 to
2022-09-30
2021-01-01 to
2021-09-30
Year to quarter end consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
-835,248,000 JPY
-979,679,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.